Answer
Reported eye disorders with mefloquine hydrochloride include common visual impairment and, at unknown frequency, cataract, blurred vision, retinal disorders and optic neuropathy, with retinal disorders and optic neuropathy potentially appearing after a delay during or after treatment.
Sources for this answer
- Lariam 250 mg tablets / Mefloquine 250 mg tabletsNeon Healthcare Ltd · emc · SmPC §4.8 Undesirable effects · Version 5Document updated
Sources checked